1. Home
  2. HRMY vs PAGS Comparison

HRMY vs PAGS Comparison

Compare HRMY & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

SELL

Current Price

$38.04

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Logo PagSeguro Digital Ltd.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$11.03

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
PAGS
Founded
2017
2006
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
HRMY
PAGS
Price
$38.04
$11.03
Analyst Decision
Buy
Buy
Analyst Count
12
16
Target Price
★ $48.25
$11.52
AVG Volume (30 Days)
750.6K
★ 3.8M
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
★ 2.36%
EPS Growth
★ 7.97
N/A
EPS
★ 1.84
N/A
Revenue
★ $868,453,000.00
N/A
Revenue This Year
$18.62
$6.50
Revenue Next Year
$13.23
$5.95
P/E Ratio
$20.62
★ $7.74
Revenue Growth
★ 21.51
N/A
52 Week Low
$25.81
$8.42
52 Week High
$43.49
$12.32

Technical Indicators

Market Signals
Indicator
HRMY
PAGS
Relative Strength Index (RSI) 42.84 64.38
Support Level $37.48 $8.61
Resistance Level $39.35 $11.58
Average True Range (ATR) 1.28 0.39
MACD -0.24 0.12
Stochastic Oscillator 50.52 88.43

Price Performance

Historical Comparison
HRMY
PAGS

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

Share on Social Networks: